Trials / Completed
CompletedNCT00256165
REST Study: Left Ventricular Regression European Study
Left Ventricular Regression European Study
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 150 (estimated)
- Sponsor
- Abbott Medical Devices · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to obtain data regarding the left ventricular mass (LVM) regression 6 months after the implant of an SJM Epic™ and SJM Epic™ Supra valve by comparing LVM regression measured with magnetic resonance imaging (MRI) to LVM regression measured with echocardiography (2-dimensional \[2D\] mandatory; 3-dimensional \[3D\] in sites where the technology is available).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Tissue valve | Aortic valve replacement |
Timeline
- Start date
- 2006-01-01
- Primary completion
- 2008-07-01
- Completion
- 2008-07-01
- First posted
- 2005-11-21
- Last updated
- 2019-02-04
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT00256165. Inclusion in this directory is not an endorsement.